Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20151022ex991e5c07f.htm |
| EX-99.4 - EX-99.4 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20151022ex9942023b2.htm |
| 8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20151022x8k.htm |
| EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20151022xex992.htm |
Exhibit 99.3
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
|
Nine-Month Periods Ended September 30, |
|||||
|
(in thousands) |
2015 |
2014 |
|||
|
Cash flows from operating activities |
|||||
|
Net loss |
$ |
(30,287) |
$ |
(47,185) | |
|
Adjustments to reconcile net loss to net cash used in operating activities |
|||||
|
Depreciation |
2,694 | 3,311 | |||
|
Amortization of debt discount and financing costs |
699 | 579 | |||
|
Stock-based compensation |
9,813 | 6,944 | |||
|
Non-cash portion of gain on lease amendments |
(3,043) |
— |
|||
|
Other items |
21 | 242 | |||
|
Changes in assets and liabilities |
|||||
|
Accounts receivable |
(758) | 376 | |||
|
Inventory |
(1,990) | (1,348) | |||
|
Prepaid expenses and other assets |
(15,410) | 85 | |||
|
Accounts payable |
364 | 4,128 | |||
|
Accrued expenses |
1,523 | 821 | |||
|
Deferred service revenue |
303 | 1,661 | |||
|
Deferred contractual revenue |
(10,788) | (5,088) | |||
|
Other liabilities |
(316) | (637) | |||
|
Net cash used in operating activities |
(47,175) | (36,111) | |||
|
Cash flows from investing activities |
|||||
|
Purchase of property and equipment |
(2,131) | (1,132) | |||
|
Disposal of property and equipment |
12 |
— |
|||
|
Purchase of investments |
(43,715) | (97,468) | |||
|
Sales of investments |
8,317 |
— |
|||
|
Maturities of investments |
68,553 | 119,673 | |||
|
Net cash provided by investing activities |
31,036 | 21,073 | |||
|
Cash flows from financing activities |
|||||
|
Proceeds from issuance of common stock from equity plans |
5,465 | 3,319 | |||
|
Proceeds from issuance of common stock from at-the-market equity offering, net of issuance costs |
1,433 | 20,768 | |||
|
Net cash provided by financing activities |
6,898 | 24,087 | |||
|
Net increase (decrease) in cash and cash equivalents |
(9,241) | 9,049 | |||
|
Cash and cash equivalents at beginning of period |
36,449 | 26,362 | |||
|
Cash and cash equivalents at end of period |
$ |
27,208 |
$ |
35,411 | |
|
Supplemental disclosure of non-cash investing and financing activities |
|||||
|
Inventory transferred to property and equipment |
1,704 |
— |
|||